In 2010, the revised hints outlined eligibility for ART amongst individuals with TB/HIV to consist of those with CD4 cell count 350 cells/mm3 and those with multidrug-resistant or extensively drug-resistant TB (MDR-TB or XDR-TB), irrespective of CD4 cell count [11]. Here, CD4 is linked to tuberculosis.